Back to search results

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Abroad (travel likely)RecruitingPHASE3

Conditions

Recurrent Nasopharyngeal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Eye& ENT Hospital, Fudan University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Xiaole Song) · jxfxsxl@163.com · 15821388769
    Contact: Principal Investigator (Hongmeng Yu)
    Xiaole Song (Sub-investigator)
    Li Yan (Sub-investigator)
    Yuting Lai (Sub-investigator)

  • Fujian Medical University Union Hospital, Fuzhou, China

    Contact: Study coordinator (Desheng Wang)
    Contact: Principal Investigator (Desheng Wang)
    Haichun Lai (Sub-investigator)

  • The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

    Contact: Study coordinator (Shenhong Qu)
    Contact: Principal Investigator (Shenhong Qu)
    Jingjin Weng (Sub-investigator)

  • Changhai Hospital, Shanghai, China

    Contact: Study coordinator (Haihong Tang)
    Contact: Principal Investigator (Haihong Tang)
    Hongliang Zheng (Sub-investigator)
    Haopu Li (Sub-investigator)
    Fengya Pan (Sub-investigator)

  • Shanghai Sixth People's Hospital, Shanghai, China

    Contact: Study coordinator (Weitian Zhang)
    Contact: Principal Investigator (Weitian Zhang)
    Ru Tang (Sub-investigator)

  • Shanghai Zhongshan Hospital, Shanghai, China

    Contact: Study coordinator (Xinsheng Huang)
    Contact: Principal Investigator (Xinsheng Huang)
    Contact: Principal Investigator (Xianhui Ning)
    Contact: Principal Investigator (Lei Zhou)

  • Shenzhen Second People's Hospital, Shenzhen, China

    Contact: Study coordinator (Yongtian Lu)
    Contact: Principal Investigator (Yongtian Lu)
    Contact: Principal Investigator (Jing Tao)
View source on ClinicalTrials.gov(opens in a new tab)